Treanda (bendamustine, SDX-105)
Published: May 9, 2009 10:15 pm
| Brand Name: | Treanda |
| Generic Name: | bendamustine |
| Code Name: | SDX-105 |
| Company: | Cephalon Oncology |
| FDA Clinical Phase: | 1/2 |
Description:
Treanda is a drug that is used to treat chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin’s lymphoma (NHL) . It is also being studied in the treatment of other types of cancer. Treanda is a type of purine analog/alkylator hybrid drug, which may damage the DNA in cancer cells and kill them.
Clinical Trials:
Currently, there are several open clinical trials studying Treanda for multiple myeloma.
Official website for Treanda: http://www.treanda.com/
Source: NCI Cancer Glossary, Treanda, http://www.cancer.gov/dictionary/?searchTxt=treanda (as of November 14, 2009)
Related Articles:
- FDA Approves Cephalon’s Treanda for Second Cancer Indication
- Beacon NewsFlashes – August 20, 2009
- New Drug Enters Phase 2 Clinical Trial For Stem Cell Collection For Blood Cancer Patients
- New Clinical Trials Combine Zolinza And Velcade For Multiple Myeloma Treatment
- Beacon NewsFlashes – March 23, 2010
Leave a comment